# A Study of Chlorhexidine in the Prevention of HIV-1 Transmission From Mothers to Their Babies

> **NCT00006075** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 150 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Chlorhexidine gluconate

## Key facts

- **NCT ID:** NCT00006075
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 150 (—)
- **Last updated:** 2008-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006075, "A Study of Chlorhexidine in the Prevention of HIV-1 Transmission From Mothers to Their Babies". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00006075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*